These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9074305)

  • 1. Magnetic resonance imaging volumetric and phosphorus 31 magnetic resonance spectroscopy measurements in schizophrenia.
    Hinsberger AD; Williamson PC; Carr TJ; Stanley JA; Drost DJ; Densmore M; MacFabe GC; Montemurro DG
    J Psychiatry Neurosci; 1997 Mar; 22(2):111-7. PubMed ID: 9074305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 31P nuclear magnetic resonance spectroscopy: neurodevelopment and schizophrenia.
    Pettegrew JW; Keshavan MS; Minshew NJ
    Schizophr Bull; 1993; 19(1):35-53. PubMed ID: 8451612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontal lobe metabolism and cerebral morphology in schizophrenia: 31P MRS and MRI studies.
    Keshavan MS; Sanders RD; Pettegrew JW; Dombrowsky SM; Panchalingam KS
    Schizophr Res; 1993 Oct; 10(3):241-6. PubMed ID: 8260442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal cortex and insight in schizophrenia: a volumetric MRI study.
    Sapara A; Cooke M; Fannon D; Francis A; Buchanan RW; Anilkumar AP; Barkataki I; Aasen I; Kuipers E; Kumari V
    Schizophr Res; 2007 Jan; 89(1-3):22-34. PubMed ID: 17097853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane phospholipid metabolism and schizophrenia: an in vivo 31P-MR spectroscopy study.
    Stanley JA; Williamson PC; Drost DJ; Carr TJ; Rylett RJ; Morrison-Stewart S; Thompson RT
    Schizophr Res; 1994 Oct; 13(3):209-15. PubMed ID: 7841133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of chronic schizophrenics using 31P magnetic resonance chemical shift imaging.
    Fujimoto T; Nakano T; Takano T; Hokazono Y; Asakura T; Tsuji T
    Acta Psychiatr Scand; 1992 Dec; 86(6):455-62. PubMed ID: 1471539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla.
    Jensen JE; Miller J; Williamson PC; Neufeld RW; Menon RS; Malla A; Manchanda R; Schaefer B; Densmore M; Drost DJ
    Psychiatry Res; 2006 Mar; 146(2):127-35. PubMed ID: 16497488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia.
    Rüsch N; Spoletini I; Wilke M; Bria P; Di Paola M; Di Iulio F; Martinotti G; Caltagirone C; Spalletta G
    Schizophr Res; 2007 Jul; 93(1-3):79-89. PubMed ID: 17383859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls.
    Tang CY; Friedman J; Shungu D; Chang L; Ernst T; Stewart D; Hajianpour A; Carpenter D; Ng J; Mao X; Hof PR; Buchsbaum MS; Davis K; Gorman JM
    BMC Psychiatry; 2007 Jun; 7():25. PubMed ID: 17578565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis.
    Suzuki M; Zhou SY; Takahashi T; Hagino H; Kawasaki Y; Niu L; Matsui M; Seto H; Kurachi M
    Brain; 2005 Sep; 128(Pt 9):2109-22. PubMed ID: 15930048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced grey and white matter volumes in the temporal lobe of male patients with chronic schizophrenia.
    Okugawa G; Sedvall GC; Agartz I
    Eur Arch Psychiatry Clin Neurosci; 2002 Jun; 252(3):120-3. PubMed ID: 12192469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between prefrontal brain volume and characteristics of memory strategy in schizophrenia spectrum disorders.
    Matsui M; Suzuki M; Zhou SY; Takahashi T; Kawasaki Y; Yuuki H; Kato K; Kurachi M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1854-62. PubMed ID: 18796324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localized volume reduction in prefrontal, temporolimbic, and paralimbic regions in schizophrenia: an MRI parcellation study.
    Yamasue H; Iwanami A; Hirayasu Y; Yamada H; Abe O; Kuroki N; Fukuda R; Tsujii K; Aoki S; Ohtomo K; Kato N; Kasai K
    Psychiatry Res; 2004 Sep; 131(3):195-207. PubMed ID: 15465289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 31P magnetic resonance spectroscopy studies in schizophrenia.
    Williamson PC; Brauer M; Leonard S; Thompson T; Drost D
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):115-8. PubMed ID: 8888133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study.
    Wible CG; Anderson J; Shenton ME; Kricun A; Hirayasu Y; Tanaka S; Levitt JJ; O'Donnell BF; Kikinis R; Jolesz FA; McCarley RW
    Psychiatry Res; 2001 Nov; 108(2):65-78. PubMed ID: 11738541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study.
    Schlösser RG; Nenadic I; Wagner G; Güllmar D; von Consbruch K; Köhler S; Schultz CC; Koch K; Fitzek C; Matthews PM; Reichenbach JR; Sauer H
    Schizophr Res; 2007 Jan; 89(1-3):1-11. PubMed ID: 17085018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder.
    Kato T; Shioiri T; Murashita J; Hamakawa H; Inubushi T; Takahashi S
    Psychiatry Res; 1994 Mar; 55(1):41-50. PubMed ID: 8047628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
    O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
    Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.